PLC Medical Systems to Display RenalGuard(TM) During Renal...( RenalGuard - An Innovative Approac...),Health

RenalGuard - An Innovative Approach to Preventing Kidney Damage during

Imaging Procedures

FRANKLIN, Mass., Nov. 1 /PRNewswire/ -- PLC Systems Inc. (Amex: PLC), a company focused on innovative cardiac and vascular medical device-based technologies, announced today that it will display the RenalGuard System(TM) during Renal Week, the American Society of Nephrology's 40th Annual Meeting and Scientific Exposition, October 31- November 5, 2007 in San Francisco, CA. This is the first public showing to nephrologists and allied health professionals in the United States.

RenalGuard(TM) is an investigational system and therapy that targets patients with compromised renal function who may be at risk for Contrast-Induced Nephropathy, or CIN, when undergoing cardiovascular imaging procedures. RenalGuard Therapy(TM) is based on initial pre-clinical study data that suggests that initiating and maintaining high urine output during imaging procedures allows the body to rapidly eliminate toxins in contrast media, reducing their harmful effects. The RenalGuard System is a fully-automated, real-time matched fluid replacement device intended for the at-risk segment of the millions of interventional cardiology and radiology patients undergoing these procedures.

"We are very pleased to have the opportunity to display our innovative RenalGuard System during Renal Week this year," stated Mark R. Tauscher, President and CEO of PLC Systems Inc. "This will be our first chance to meet with a large number of Nephrologists and we are looking forward to the feedback we will receive."

Earlier this year, the company announced the successful enrollment of the first patients in its FDA-approved pilot
'/>"/>